Reaction

Physical Disability reporting signals

Last recalculated 2026-09-14T18:28:35.993900+00:00 · 4,397 reports · 105 co-occurring drugs

As of the last recalculation, Physical Disability appears in 4,397 FAERS reports alongside 105 co-occurring drug terms. The strongest observed disproportionality signal is DIVALPROEX SODIUM (PRR 62.9).

Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.

Drug	Co-reports	PRR	ROR
Divalproex Sodium	543	62.9	63.6
Methimazole	33	20.0	20.1
Ciprofloxacin Hydrochloride And Hydrocortisone	82	19.0	19.1
Testosterone Cypionate	31	16.5	16.6
Chlorhexidine Gluconate	28	14.6	14.6
Diclofenac Potassium, Film Coated	25	14.1	14.2
Diclofenac Potassium Tablets	25	14.1	14.2
Diclofenac Potassium	25	11.0	11.0
Testosterone	50	10.2	10.2
Calcium Gluconate	25	9.9	9.9
Sulfasalazine	155	9.7	9.7
Hydroxychloroquine Sulfate	178	9.6	9.6
Adalimumab-Fkjp	90	9.4	9.4
Cortisone Acetate	24	9.2	9.3
Adalimumab-Aaty	90	9.2	9.2
Hydrocodone Bitartrate And Acetaminophen	104	8.9	8.9
Adalimumab-Adaz	90	8.2	8.2
Leflunomide	175	8.2	8.2
Tocilizumab	185	8.0	8.0
Tofacitinib Citrate	21	7.6	7.6
Meperidine Hydrochloride	13	6.7	6.7
Ciprofloxacin	122	6.4	6.5
Ciprofloxacin Hydrochloride	126	6.3	6.3
Abatacept	177	6.3	6.3
Desoximetasone	25	6.2	6.2
Diclofenac Sodium 1%	39	5.2	5.2
Diclofenac Sodium Topical	39	5.2	5.2
Diclofenac Sodium Topical Gel, 1%	39	5.2	5.2
Finasteride	59	4.7	4.7
Prednisolone Acetate	10	4.6	4.6
Standardized Senna Concentrate	12	4.5	4.5
Bicalutamide	14	4.4	4.4
Clindamycin	26	4.4	4.4
Liothyronine Sodium	8	4.4	4.4
Clindamycin Phosphate	30	4.3	4.3
Terazosin Hydrochloride	8	4.3	4.3
Oxycodone Hydrochloride	189	4.3	4.3
Magnesium Hydroxide	12	4.2	4.2
Dorzolamide Hydrochloride And Timolol Maleate	7	4.2	4.2
Cephalexin	19	4.2	4.2
Temazepam	33	4.2	4.2
Infliximab	186	4.2	4.2
Cefazolin	8	4.2	4.2
Pseudoephedrine Hydrochloride	9	4.2	4.2
Docusate Sodium - Sennosides	28	4.1	4.1
Erythromycin	16	4.0	4.1
Hydromorphone Hydrochloride	77	4.0	4.0
Epoetin Alfa	10	4.0	4.0
Pseudoephedrine Hcl	9	3.9	3.9
Meclizine Hcl 12.5Mg	11	3.8	3.8
Meclizine Hcl 25Mg	11	3.8	3.8
Meclizine Hcl 12.5 Mg	11	3.8	3.8
Meclizine Hcl 25 Mg	11	3.8	3.8
Meclizine	13	3.8	3.8
Methocarbamol Tablets	13	3.7	3.7
Exemestane	16	3.5	3.5
Cefazolin Sodium	9	3.5	3.5
Carboxymethylcellulose Sodium	7	3.5	3.5
Drospirenone And Ethinyl Estradiol	32	3.4	3.4
Famotidine	84	3.4	3.4
Timolol Maleate	7	3.3	3.4
Metoclopramide	38	3.3	3.3
Clopidogrel	134	3.3	3.3
Certolizumab Pegol	79	3.2	3.2
Hydroxychloroquine	50	3.2	3.2
Lifitegrast	11	3.2	3.2
Fulvestrant	22	3.2	3.2
Cetirizine Hydrochloride Allergy	20	3.1	3.1
Cetirizine Hydrochloride Tablets	20	3.1	3.1
Melphalan	15	3.1	3.1
Rituximab	133	3.0	3.0
Metoclopramide Hydrochloride	49	3.0	3.0
Iohexol	5	2.9	2.9
Melphalan Hydrochloride	15	2.8	2.8
Conjugated Estrogens And Medroxyprogesterone Acetate	14	2.8	2.8
Methadone	25	2.8	2.8
Brentuximab Vedotin	6	2.8	2.8
Propofol	21	2.7	2.7
Aripiprazole	69	2.7	2.7
Tobramycin Sulfate	7	2.7	2.7
Tofacitinib	102	2.7	2.7
Thalidomide	20	2.6	2.6
Tiotropium Bromide Inhalation Spray	6	2.5	2.5
Lurasidone Hydrochloride	11	2.5	2.5
Cladribine	5	2.5	2.5
Oxycodone Hydrochloride And Acetaminophen	51	2.5	2.5
Buprenorphine Hydrochloride, Naloxone Hydrochloride	12	2.4	2.4
Ziprasidone Mesylate	7	2.3	2.3
Botulinum Toxin Type A	6	2.3	2.3
Suvorexant	6	2.2	2.2
Morphine Sulfate	50	2.0	2.0
Etanercept	233	1.9	1.9
Golimumab	34	1.9	1.9
Mometasone Furoate And Formoterol Fumarate Dihydrate	6	1.8	1.8
Rifaximin	8	1.8	1.8
Teriflunomide	16	1.7	1.7
Cariprazine	3	1.5	1.5
Paliperidone Palmitate	9	1.3	1.3
Hydrocodone Bitartrate	12	1.3	1.3
Bictegravir Sodium, Emtricitabine, And Tenofovir Alafenamide Fumarate	5	1.3	1.3
Ranitidine Hydrochloride	14	1.2	1.2
Sarilumab	6	1.1	1.1
Buprenorphine	19	1.0	1.0
Bimekizumab	4	0.9	0.9
Nirmatrelvir And Ritonavir	6	0.5	0.5

Related reactions

Data source: openFDA FAERS. See the OpenPV methodology and limitations.